Home Page
10.29.2004
 Fantasyland[s] 
The latest Fortune (Nov. 1, 2004) (subscription required) has a column by Geoffrey Colvin on how "Both candidates are on a drug trip to fantasyland" over the issue of re-importation from Canada.

In a few words, he neatly sums up the problem: Pharmaceuticals are an industry that requires massive investment to produce the first pill, then only pennies each to produce the next zillion. So the system is that U.S. consumers pay for the investment, then foreign governments bargain with the drug companies, pushing the price down toward marginal cost and free riding on the original investment by the U.S. consumers.

This is exactly what Canada does, by controlling prices so they are 70% lower than those in the U.S. So politicians who want to force re-importation so as to lower prices believe that "by enacting a law, they can make the U.S. a free rider on itself. In fantasyland, no one would have to pay for drug development at all."

He continues: "The real issue is the excruciating choice between higher drug quality and availability on the one hand, and lower costs on the other. In the real world, where nothing is free, you can't have both." (Except I disagree with his use of the adjective "excruciating" to describe a trade-off that is simply inherent in the nature of the world.)

Colvin could have pointed out that pharmaceuticals are not the only fantasyland around. Debate about all kinds of content and delivery systems -- music, movies, publishing, software, games, file-sharing, TiVo, and so on -- is permeated with the same type of delusion -- that because the marginal cost of distribution is so low, content should be dirt-cheap, and we should all get to free ride, ignoring the cost of creation.

Years ago, I heard a radio interview with noted economist and de-regulator Alfred Kahn, in which the professor was finally moved to say to his economically illiterate torturer, with infinite weary exasperation in his voice, "But we can't all of us subsidize all of us; the world simply does not work that way."

posted by James DeLong : 10/29/2004 09:56:09 AM

This page is powered by Blogger. Isn't yours?

 

IPcentral WebLog
Blog Main
Recent Posts
  European Site Opposing Software Patents
Grokster Settles Copyright Suit
Antitrust Doctrine, IP, Property, and Dynamic Efficiency
Bureaucracy
More Reading
Posner on Law Reviews
Bush & Kerry on P2P
Patents, Litigation and Innovation
The New Business Model Argument Again
Hal Varian reviews Jaffe and Lerner book
Archives by Month
  December 2003
January 2004
February 2004
March 2004
April 2004
May 2004
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
Links
  PFF Blog
Atom.xml Site Feed
   
 
Home Page IPcentral Weblog - Intellectual Property and Copyright Commentary
Home Page
10.29.2004
 Fantasyland[s] 
The latest Fortune (Nov. 1, 2004) (subscription required) has a column by Geoffrey Colvin on how "Both candidates are on a drug trip to fantasyland" over the issue of re-importation from Canada.

In a few words, he neatly sums up the problem: Pharmaceuticals are an industry that requires massive investment to produce the first pill, then only pennies each to produce the next zillion. So the system is that U.S. consumers pay for the investment, then foreign governments bargain with the drug companies, pushing the price down toward marginal cost and free riding on the original investment by the U.S. consumers.

This is exactly what Canada does, by controlling prices so they are 70% lower than those in the U.S. So politicians who want to force re-importation so as to lower prices believe that "by enacting a law, they can make the U.S. a free rider on itself. In fantasyland, no one would have to pay for drug development at all."

He continues: "The real issue is the excruciating choice between higher drug quality and availability on the one hand, and lower costs on the other. In the real world, where nothing is free, you can't have both." (Except I disagree with his use of the adjective "excruciating" to describe a trade-off that is simply inherent in the nature of the world.)

Colvin could have pointed out that pharmaceuticals are not the only fantasyland around. Debate about all kinds of content and delivery systems -- music, movies, publishing, software, games, file-sharing, TiVo, and so on -- is permeated with the same type of delusion -- that because the marginal cost of distribution is so low, content should be dirt-cheap, and we should all get to free ride, ignoring the cost of creation.

Years ago, I heard a radio interview with noted economist and de-regulator Alfred Kahn, in which the professor was finally moved to say to his economically illiterate torturer, with infinite weary exasperation in his voice, "But we can't all of us subsidize all of us; the world simply does not work that way."

posted by James DeLong : 10/29/2004 09:56:09 AM

This page is powered by Blogger. Isn't yours?

 

IPcentral WebLog
Blog Main
Recent Posts
  European Site Opposing Software Patents
Grokster Settles Copyright Suit
Antitrust Doctrine, IP, Property, and Dynamic Efficiency
Bureaucracy
More Reading
Posner on Law Reviews
Bush & Kerry on P2P
Patents, Litigation and Innovation
The New Business Model Argument Again
Hal Varian reviews Jaffe and Lerner book
Archives by Month
  December 2003
January 2004
February 2004
March 2004
April 2004
May 2004
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
Links
  PFF Blog
Atom.xml Site Feed
   
 
Home Page